{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:40:01Z","timestamp":1761568801327,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clgc.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T13:45:21Z","timestamp":1494423921000},"page":"e943-e954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the Clinical Utility of Renin-Angiotensin System Inhibitors in Patients Undergoing Radical Surgery for Urothelial Carcinoma of the Upper Urinary Tract"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1119-312X","authenticated-orcid":false,"given":"Takashi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Murota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Kawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2017.05.003_bib1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2017.05.003_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.urology.2010.04.020","article-title":"Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma","volume":"76","author":"Abouassaly","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2017.05.003_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2017.05.003_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","article-title":"European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update","volume":"68","author":"Roupr\u00eat","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2017.05.003_bib5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/13543784.2015.1041588","article-title":"Targeting the VEGF pathway in metastatic bladder cancer","volume":"24","author":"Mazzola","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.clgc.2017.05.003_bib6","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1158\/1078-0432.CCR-05-2213","article-title":"Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer","volume":"12","author":"Kosugi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2017.05.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-0774.2007.00025.x","article-title":"Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer","volume":"20","author":"Kosugi","year":"2007","journal-title":"Hum Cell"},{"key":"10.1016\/j.clgc.2017.05.003_bib8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/bjc.2011.399","article-title":"Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer","volume":"105","author":"Tanaka","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2017.05.003_bib9","doi-asserted-by":"crossref","first-page":"1009.e19","DOI":"10.1016\/j.urology.2010.11.002","article-title":"Angiotensin II type 1 receptor expression\u00a0and microvessel density in human bladder cancer","volume":"77","author":"Shirotake","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2017.05.003_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/bjc.2011.565","article-title":"Prognostic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma","volume":"106","author":"Tanaka","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2017.05.003_bib11","article-title":"Preoperative pyuria is a poor prognostic factor in patients with urothelial carcinoma of the upper urinary tract after surgery [e-pub ahead of print]","author":"Yoshida","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2017.05.003_bib12","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.clgc.2017.05.003_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.trsl.2014.05.001","article-title":"Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities","volume":"164","author":"Cavalera","year":"2014","journal-title":"Transl Res"},{"key":"10.1016\/j.clgc.2017.05.003_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11892-004-0055-z","article-title":"Transforming growth factor-beta: a clinical\u00a0target for the treatment of diabetic nephropathy","volume":"4","author":"McGowan","year":"2004","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.clgc.2017.05.003_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1746.2006.04797.x","article-title":"Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases","volume":"22","author":"Neo","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clgc.2017.05.003_bib16","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.3892\/mmr.2015.3849","article-title":"Angiotensin II type 1 receptor-associated protein plays a role in regulating the local renin-angiotensin system in HSC-T6 cells","volume":"12","author":"Huang","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.clgc.2017.05.003_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/157488709788185996","article-title":"Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in urogenital cancer","volume":"4","author":"Miyajima","year":"2009","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.clgc.2017.05.003_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcp.22209","article-title":"Angiotensin II\/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase\/Akt pathway","volume":"225","author":"Zhao","year":"2010","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.clgc.2017.05.003_bib19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/iju.12827","article-title":"Renin-angiotensin system blockade: its contribution and controversy","volume":"22","author":"Miyajima","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.clgc.2017.05.003_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2017.05.003_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/CEJ.0000000000000269","article-title":"The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis","volume":"26","author":"Song","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.clgc.2017.05.003_bib22","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1245\/s10434-012-2568-z","article-title":"Prognostic value of renin-angiotensin system\u00a0blockade in non-muscle-invasive bladder cancer","volume":"19","author":"Yuge","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clgc.2017.05.003_bib23","first-page":"1214","article-title":"Renin-angiotensin inhibitors decrease recurrence after transurethral resection of bladder tumor in patients with nonmuscle invasive bladder cancer","volume":"194","author":"Blute","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2017.05.003_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1245\/s10434-016-5534-3","article-title":"Prognostic impact of renin-angiotensin inhibitors in patients with bladder cancer undergoing radical cystectomy","volume":"24","author":"Yoshida","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clgc.2017.05.003_bib25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","article-title":"Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma","volume":"35","author":"Seisen","year":"2017","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317301271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767317301271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:27:32Z","timestamp":1761564452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767317301271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1558767317301271"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2017.05.003","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Clinical Utility of Renin-Angiotensin System Inhibitors in Patients Undergoing Radical Surgery for Urothelial Carcinoma of the Upper Urinary Tract","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}